Power3 Medical Products, Inc. (OTC:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that Power3 Medical Products has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 Medical Products plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3 Medical Products, with Power3 Medical Products remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.
"We are very excited to be acquiring Rozetta-Cell Life Sciences," stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. "Rozetta-Cell brings us a tremendous amount of complementary adult stem cell therapy technology, know-how and experience. With the addition of Rozetta-Cell, Power3 will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that we are using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs."
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical Products applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Honeywell (NYSE:HON) declared a strategic partnership with Barrier Sciences Group (BSG), the pioneer in residential and commercial building envelope projects in Canada, to bring Enovate™PRO products from Honeywell's Weatherization Contractor Program to the Canadian marketplace.
Under the partnership, BSG will establish a network of professionally trained contractors to install weatherization products, which are available only to contractors who are certified under Honeywell's Weatherization Contractor Program.
Honeywell International is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials.
Hong Kong Highpower Technology, Inc. (NASDAQ:HPJ), a developer, manufacturer and marketer of nickel-metal hydride (Ni-MH) and lithium-ion (Li-ion) rechargeable batteries and related products, reported that it will exhibit advanced battery technologies at the following international battery industry conferences in the coming months:
Electronica 2010 (24th International Trade Fair & New Munich Trade Fair) on November 9-12, 2010, at New Munich Trade Fair Centre in Germany. For more information, visit: www.electronica.de/en.
2011 International CES on January 6-9, 2011, at Las Vegas Convention Center in the United States. For more information, visit: www.cesweb.org/.
Hong Kong Highpower Technology develops, manufactures and markets rechargeable nickel metal hydride (Ni-MH) and lithium-ion (Li-ion) batteries and related products for use in a variety of electronic devices. The majority of Hong Kong Highpower Technology's products are distributed worldwide to markets in the United States, Europe, China, Hong Kong, Southeast Asia and Taiwan.
As part of its commitment to helping life sciences organizations discover, develop, and market innovative products that prevent and cure diseases, Oracle Health Sciences has strengthened its analytics offerings with the release of Oracle Corp. (NASDAQ:ORCL) Clinical Development Analytics 2.0 and Oracle Life Sciences Data Hub 2.1.4. Oracle's life sciences analytics solutions help organizations accelerate insight and increase research and development efficiency. Oracle Clinical Development Analytics 2.0 expands beyond the product's original focus on clinical data management to provide rich content for clinical operations.
Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide.
True 2 Beauty, Inc. (Pinksheets:TRTB), a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, declared the "Libigrow" family of products is being featured in its booth at the National Association of Convenience Stores (NACS) Trade Show in Atlanta Georgia Oct. 6th, 7th and 8th in Booth 6111. The U.S. convenience store industry has 144,000-plus stores that account for more than $624 billion in sales.
Alex Hbaiu, President and CEO of True 2 Beauty, Inc., stated, "Showcasing our Libigrow family of products to the largest trade show of its kind should quickly expand our market reach in the U.S. and around the world for the Libigrow family of products and our reception here has been wonderful."
True 2 Beauty, Inc. is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).